Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Shanghai Institute Of Materia Medica Chinese Academy Of Sciences patents


Recent patent applications related to Shanghai Institute Of Materia Medica Chinese Academy Of Sciences. Shanghai Institute Of Materia Medica Chinese Academy Of Sciences is listed as an Agent/Assignee. Note: Shanghai Institute Of Materia Medica Chinese Academy Of Sciences may have other listings under different names/spellings. We're not affiliated with Shanghai Institute Of Materia Medica Chinese Academy Of Sciences, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "S" | Shanghai Institute Of Materia Medica Chinese Academy Of Sciences-related inventors


Certain protein kinase inhibitors

Provided are certain PI3K inhibitors, pharmaceutical compositions thereof, and methods of use therefor.... Shanghai Institute Of Materia Medica Chinese Academy Of Sciences

Crystal form a of compound and preparation method thereof

The present invention relates to crystal form A of a compound. The present invention also discloses a preparation method and a pharmaceutical composition of the crystal form A. The crystal form A has strong hypoglycemic activity in vivo and is expected to be a novel pharmaceutically active ingredient for treating... Shanghai Institute Of Materia Medica Chinese Academy Of Sciences

Pyrimidone compounds used as lp-pla2 inhibitors and pharmaceutical compositions thereof

The present invention relates to pyrimidone compounds used as Lp-PLA2 inhibitors and pharmaceutical compositions thereof. The structure of the pyrimidone compounds is represented by general formula (I), wherein R1, R2, R3, X, Ar, Y and n are defined as in the specification and claims. The compounds of general formula (I)... Shanghai Institute Of Materia Medica Chinese Academy Of Sciences

Six-membered ring benzo derivatives as dpp-4 inhibitor and use thereof

The present invention relates to six-membered ring benzo derivatives as a DPP-4 inhibitor and a use thereof. In particular, the present invention relates to a compound as shown in formula I, a pharmaceutical composition containing the compound as shown in formula I and a use of the compound in the... Shanghai Institute Of Materia Medica Chinese Academy Of Sciences

Aminosulfonyl compound, preparation method therefor and use thereof

Disclosed are aminosulfonyl-based compounds represented by the general formula I or tautomers, enantiomers, racemates or pharmaceutically acceptable salts thereof, a method for preparing the same, pharmaceutical compositions and uses thereof. The compounds can be used to treat epilepsy, convulsions, obesity and the like.... Shanghai Institute Of Materia Medica Chinese Academy Of Sciences

2-aminopyrimidine compound and pharmaceutical composition and use thereof

Disclosed are a 2-aminopyrimidine compound and pharmaceutical composition and use thereof. The structure of the 2-aminopyrimidine compound is as represented by formula I, in the formula, R1, R2, R3, R4, R5, X, Y, Z, W, (i) being as defined in the specification and the claims. Such compounds effectively inhibit the... Shanghai Institute Of Materia Medica Chinese Academy Of Sciences

Indazole compounds as fgfr kinase inhibitor, preparation and use thereof

The present invention provides an indazole compound as a FGFR kinase inhibitor, preparation and use thereof. Specifically, the present invention provides a compound represented by formula (I), wherein the definitions of each group are described in the specification. The compound of the present invention has good FGFR kinase-inhibiting activity, and... Shanghai Institute Of Materia Medica Chinese Academy Of Sciences

One class of pyrazolone compounds and use thereof

Provided are a class of pyrazolone compounds and a use thereof. In particular, a compound represented by formula I is provided, wherein the definition of each variable group is as described in the description. The compounds of formula (I) have a direct AMPK-activating activity and can significantly promote the phosphorylation... Shanghai Institute Of Materia Medica Chinese Academy Of Sciences

Heterocyclic compounds, process for preparation of the same and use thereof

The present invention provides a heterocyclic compound represented by the formula (I), its stereoisomers, or a pharmaceutically acceptable salt thereof, pharmaceutical compositions thereof, and their use in preparing a medicament for the prevention and/or treatment of central nervous system disease.... Shanghai Institute Of Materia Medica Chinese Academy Of Sciences

Anti-tumor use of anagrelide and derivatives thereof

The present invention provides an anti-tumor use of Anagrelide and derivatives thereof and, more specifically, the present invention provides the use of Anagrelide and derivatives thereof in the preparation of pharmaceuticals or pharmaceutical compositions for the treatment or inhibition of tumors.... Shanghai Institute Of Materia Medica Chinese Academy Of Sciences

High-purity magnesium lithospermate b and preparation method therefor

The present invention relates to a method for preparing magnesium lithospermate B. The method is characterized in that: magnesium lithospermate B is extracted or purified from a Salvia miltiorrhiza plant material or a Salvia miltiorrhiza extract in the presence of an added magnesium salt. The present invention also relates to... Shanghai Institute Of Materia Medica Chinese Academy Of Sciences

Substituted nitrogen-containing heterocyclic derivatives, pharmaceutical compositions comprising the same and applications ofantitumor thereof

Disclosed are new substituted nitrogen-containing heterocyclic derivatives represented by formula (I) as AKT inhibitors, optical isomers, pharmaceutically acceptable salts or solvates thereof, wherein the definition of R1, R2, R3, R4, R5, R6, ring A, ring C, B, Q, Y, Z and m is shown in the description for details. In... Shanghai Institute Of Materia Medica Chinese Academy Of Sciences

Glechoma longitube extract, preparation same, and use thereof in sugar reduction, weight loss, and lipid reduction

Disclosed is a Glechoma longituba (Nakai) Kupr. extract, specifically compounds I and II, a preparation method for same, and a use thereof in preparing a medicament for blood glucose decease, blood lipids decrease, weight loss, and kidney disease treatment or a method for treatment of said diseases, and a composition... Shanghai Institute Of Materia Medica Chinese Academy Of Sciences

Novel kcnq potassium channel agonists, preparation and use thereof

The present invention provides a compound represented by general formula I or a pharmaceutical acceptable salt thereof, the preparation method therefor and the use thereof in preparing a medicine for treating a neurological disease, such as epilepsy, convulsion, neuropathic pain, acute ischemic stroke, and a neurodegenerative disease. The compound according... Shanghai Institute Of Materia Medica Chinese Academy Of Sciences

Naphthylamide compound, preparation method and use thereof

The present invention relates to a naphthylamide compound of the structure as represented by formula (I), medicinal salts, prodrugs and hydrates or solvates thereof, and also relates to a method of preparing the compounds, pharmaceutical compositions comprising the compounds and the uses thereof as protein tyrosine kinase inhibitors, particularly as... Shanghai Institute Of Materia Medica Chinese Academy Of Sciences

2,2'-tandem dithiazole compound, preparation method therefor, and use thereof

The present invention relates to a thiazole-based compound, a preparation method therefor, and a use thereof. More specifically, the present invention relates to a 2,2′-bis-thiazole-based compound, a preparation method therefor, and a use of 2,2′-bis-thiazole-based compound a histone deacetylase inhibitor in the preparation of an antitumor medicament, a medicament for... Shanghai Institute Of Materia Medica Chinese Academy Of Sciences

1-(3-aminopropyl) substituted cyclic amine compounds, preparation method therefor, and pharmaceutical compositions and uses thereof

Provided are 1-(3-aminopropyl) substituted cyclic amine compounds as represented by formula (I), pharmaceutically acceptable salts, enantiomers, diastereoisomers, racemates and mixtures thereof, and a method of synthesizing said 1-(3-aminopropyl) substituted cyclic amine compounds by using aromatic heterocyclic formaldehyde as raw material. Said compounds can be used as CCR 5 antagonist for... Shanghai Institute Of Materia Medica Chinese Academy Of Sciences

Pyrrolo[2,1-f[1,2,4]triazine compounds, preparation methods and applications thereof

The present invention relates to a pyrrolo[2,1-f][1,2,4]triazine compound, an isomer thereof or a pharmaceutically acceptable salt, ester or hydrate thereof, and a preparation method and application thereof. The pyrrolo[2,1-f][1,2,4]triazine compound has a structure expressed in general formula (I). The pyrrolo[2,1-f][1,2,4]triazine compound expressed in general formula (I) can inhibit a phosphatidylinositol-3... Shanghai Institute Of Materia Medica Chinese Academy Of Sciences








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Shanghai Institute Of Materia Medica Chinese Academy Of Sciences in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Shanghai Institute Of Materia Medica Chinese Academy Of Sciences with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###